Skip to main content
QuestionsResearchTagsGuidelinesLeaderboard
tachyDx Research Portal

Research tagged [endocrinology]

Every paper is generated from a real clinical discussion on tachyDx, peer-reviewed by verified physicians, and published with a unique TDX identifier. All contributors are credited.

DOIs registered viaCrossref
Published26Under ReviewFlagged
Clear filters

2 papers

TDX-2026-00016

Optimizing Potassium Replacement and Insulin Initiation in Diabetic Ketoacidosis with Initial Hypokalemia: A Peer-Reviewed Clinical Consensus

Background: Diabetic ketoacidosis (DKA) is a severe metabolic emergency characterized by hyperglycemia, ketonemia, and acidosis. Despite the extracellular shift of potassium (K+) in acidosis, initial hypokalemia is observed in a significant proportion of DKA patients, indicating a profound total body K+ deficit. The timing of insulin initiation in such cases presents a critical clinical dilemma, balancing the urgent need for acidosis correction against the risk of precipitous K+ decline and subsequent cardiac arrhythmias. Methods: This consensus paper synthesizes expert opinion from two verified physicians within the tachyDx peer-review community, supported by 72 community peer votes. The discussion focused on a 28-year-old male presenting with DKA and initial serum K+ of 3.1 mEq/L. Key areas of inquiry included the aggressiveness and route of K+ replacement, concurrent K+ infusion rates with insulin, and the role of phosphate and magnesium supplementation. Results: A consensus emerged advocating for aggressive K+ replacement (e.g., 40 mEq KCl via central line over 1 hour) prior to insulin initiation, with a recommended threshold of K+ ≥ 3.5 mEq/L. Central venous access was preferred for high-rate infusions, with peripheral alternatives outlined. Concurrent K+ infusion at 20-40 mEq/hr was advised during insulin therapy, targeting serum K+ of 4.0-5.0 mEq/L. Modified insulin dosing (0.05 units/kg/hr) was suggested for K+ < 3.5 mEq/L. The importance of magnesium monitoring and replacement, alongside judicious potassium phosphate use for hypophosphatemia, was emphasized. Bicarbonate administration was generally discouraged. Conclusions: This peer-reviewed consensus provides practical, evidence-informed guidance for managing initial hypokalemia in DKA. The recommendations prioritize patient safety by mitigating arrhythmia risk while facilitating timely DKA resolution, offering a refined approach to electrolyte management in this complex clinical scenario.

A physician-only Q&A platform where verified medical doctors share clinical knowledge, debate evidence, and build the knowledge base the world needs.

Powered by

Platform

  • Questions
  • Research
  • Tags
  • Guidelines
  • Leaderboard
  • Report a Bug

Ecosystem

  • Teams
  • Sponsors
  • Hiring
  • Publishing
  • CME
  • Data

Company

  • About
  • Support
  • Privacy Policy
  • Terms of Service
  • Contact

© 2026 Aethryva Deeptech Pvt Ltd. All rights reserved.

Crossref Member
2 contributors 72 votes 6 Apr 2026

TDX-2026-00006

Management of Thyroid Storm with Severe Asthma: A Community Peer-Reviewed Clinical Consensus on Non-Beta-Blocker Rate Control and Adjunctive Therapies

Thyroid storm represents a life-threatening endocrine emergency characterized by exaggerated manifestations of thyrotoxicosis. Rapid heart rate control is critical, typically achieved with beta-adrenergic receptor blockers. However, the presence of severe comorbid conditions, such as severe asthma, can contraindicate standard beta-blocker therapy, posing a significant clinical challenge. This paper synthesizes a clinical discussion from the tachyDx community peer-review platform regarding the optimal management strategy for a 28-year-old male presenting with thyroid storm and severe asthma, specifically focusing on rate control alternatives and comprehensive adjunctive treatments. Methods: This case-based discussion was initiated by a verified endocrinologist on a specialized clinical Q&A platform, attracting input from another verified physician and garnering 68 community peer votes. The methodology involved expert clinical opinion exchange, evaluation of therapeutic alternatives, and consensus building on a complex patient presentation. The final management approach, which led to a successful clinical outcome, was subsequently shared and validated. Results: The consensus approach involved intravenous diltiazem for heart rate control, achieving a reduction from 156 to 94 bpm within four hours without precipitating bronchospasm. The comprehensive thyroid storm regimen included propylthiouracil (PTU), saturated solution of potassium iodide (SSKI), hydrocortisone, and cholestyramine. This multifaceted intervention resulted in a dramatic clinical improvement, with the Burch-Wartofsky score decreasing from 55 to 20 within three days. Conclusions: Diltiazem emerges as a safe and effective alternative for rapid heart rate control in thyroid storm patients with severe asthma where beta-blockers are contraindicated. The case reinforces the importance of a multi-modal therapeutic strategy targeting hormone synthesis, release, peripheral conversion, and enterohepatic recirculation, tailored to individual patient comorbidities.

2 contributors 68 votes 6 Apr 2026
Page 1 of 2Next →

Topics

Allpharmacology8critical-care7cardiology6emergency-medicine6oncology5pulmonology5nephrology4neurology4gastroenterology3immunology3hematology3surgery3infectious-disease3radiology2endocrinology2anesthesiology2hepatology2pediatrics2rheumatology2evidence-based-medicine1orthopedics1trauma1neonatology1psychiatry1internal-medicine1